Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Isolation and rapid sharing of the 2019 novel coronavirus ( SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Australia

(2020) Leon Caly et al.   MEDICAL JOURNAL OF AUSTRALIA

Multiorgan and Renal Tropism of SARS-CoV-2

(2020) Victor G. Puelles et al.   NEW ENGLAND JOURNAL OF MEDICINE

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

(2020) Bernard La Scola et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

SARS-CoV-2 viral load predicts COVID-19 mortality

(2020) Elisabet Pujadas et al.   Lancet Respiratory Medicine

Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays

(2020) Edward I Patterson et al.   JOURNAL OF INFECTIOUS DISEASES

Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes

(2020) Sacha Stelzer-Braid et al.   PATHOLOGY

Assessment of a swab collection method without virus transport medium for PCR diagnosis of coxsackievirus infections

(2018) Maria Borsanyiova et al.   JOURNAL OF VIROLOGICAL METHODS

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes

(2016) Theone C. Kon et al.   PLoS One

Aggregation and antigenicity of virus like particle in salt solution—A case study with hepatitis B surface antigen

(2015) Yi Chen et al.   VACCINE

Surface modifications of influenza proteins upon virus inactivation by β-propiolactone

(2013) Yi-Min She et al.   PROTEOMICS

Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges

(2012) Iris Delrue et al.   Expert Review of Vaccines

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Hepatitis C Virus NS5A Binds to the mRNA Cap-binding Eukaryotic Translation Initiation 4F (eIF4F) Complex and Up-regulates Host Translation Initiation Machinery through eIF4E-binding Protein 1 Inactivation

(2011) Anju George et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effect of the β-Propiolactone Treatment on the Adsorption and Fusion of Influenza A/Brisbane/59/2007 and A/New Caledonia/20/1999 Virus H1N1 on a Dimyristoylphosphatidylcholine/Ganglioside GM3 Mixed Phospholipids Monolayer at the Air–Water Interface

(2011) Bernard Desbat et al.   LANGMUIR

Cytotoxic T Cells Are the Predominant Players Providing Cross-Protective Immunity Induced by  -Irradiated Influenza A Viruses

(2010) Y. Furuya et al.   JOURNAL OF VIROLOGY

Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine

(2010) Anjeanette Roberts et al.   VIRAL IMMUNOLOGY

Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines

(2008) R. H. See et al.   JOURNAL OF GENERAL VIROLOGY

Dry cotton or flocked respiratory swabs as a simple collection technique for the molecular detection of respiratory viruses using real-time NASBA

(2008) Catherine Moore et al.   JOURNAL OF VIROLOGICAL METHODS